| 中文名称: | 坦度替尼 |
| 中文别名: | 4-[6-甲氧基-7-(3-哌啶-1-基丙氧基)喹唑啉-4-基]-N-(4-异丙基氧苯基)哌嗪-1-甲酰胺;坦度替尼(标准品);坦度替尼;Tandutinib(MLN518) 抑制剂;坦度替尼Tandutinib;坦度替尼(对照品) |
| smiles: | O(C1=C(C([H])=C2C(=C1[H])N=C([H])N=C2N1C([H])([H])C([H])([H])N(C(N([H])C2C([H])=C([H])C(=C([H])C=2[H])OC([H])(C([H])([H])[H])C([H])([H])[H])=O)C([H])([H])C1([H])[H])OC([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])N1C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H] |
| 英文名称: | Tandutinib (MLN518) |
| 英文别名: | Tandutinib;CT53518;MLN518;1-Piperazinecarboxamide, 4-(6-methoxy-7-(3-(1-piperidinyl)propoxy)-4-quinazolinyl)-N-(4-(1-methylethoxy)phenyl)-;4-(6-Methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-yl)piperazine-1-carboxylic acid (4-isopropoxyphenyl)amide;Unii-E1io3icj9a;Tandutinib(CT 53518);Tandutinib (MLN518);4-[6-Methoxy-7-[3-(1-piperidinyl)propoxy]-4-quinazolinyl]-N-[4-(1-Methylethoxy)phenyl]-;N-(4-isopropoxyphenyl)-4-(6-methoxy-7-(3-(piperidin-1-yl)propoxy)quinazolin-4-yl)piperazine-1-carboxamide;CT-53518;MLN-518;Tandutinib for research;4-[6-Methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-yl]-N-(4-propan-2-yloxyphenyl)piperazine-1-carboxamide;(4-(6-Methoxy-7-(3-piperidylpropoxy)quinazolin-4-yl)piperazinyl)-N-(4-(methylethoxy)phenyl);(4-(6-Methoxy-7-(3-piperidylpropoxy)quinazolin-4-yl)piperazinyl)-N-(4-(methylethoxy)phenyl)carboxamide;MLN 518;CT 53518;E1IO3ICJ9A;NSC726292;DSSTox_RID_83142;DSSTox_CID_28873;DSSTox_GSID_48947;4-{6-methoxy-7-[3-(piperidin-1-yl)propoxy]quin;Tandutinib (USAN/INN);4-[6-Methoxy-7-[3-(1-piperidinyl)propoxy]-4-quinazolinyl]-N-[4-(1-methylethoxy)phenyl]-1-piperazinecarboxamide;NSC800942;4-[6-methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-yl]-N-(4-propan-2-yloxyphenyl)piperazine-1-carboxamide;NSC-759851;DTXSID8048947;NSC 759851;4-[6-Methoxy-7-[3-(piperidin-1-yl)propoxy]quinazolin-4-yl]-N-[4-(1-methylethoxy)phenyl]piperazine-1-carboxamide;Pharmakon1600-01502277;AMY32698;AC-1659;Tandutinib [USAN];NS00069682;UNII-E1IO3ICJ9A;Tox21_113366;1227636-17-0;TANDUTINIB (CT53518);TANDUTINIB [WHO-DD];DTXCID5028873;MLN-0518;HMS3654O09;NSC759851;HMS3244A22;Tox21_113366_1;N-(4-isopropoxyphenyl)-4-[6-methoxy-7-[3-(1-piperidyl)propoxy]quinazolin-4-yl]piperazine-1-carboxamide;HMS3244B21;BCP01370;NSC-760841;cid_3038522;EX-A1637;SMR004702776;HMS3745A09;N-(4-isopropoxyphenyl)-4-[6-methoxy-7-(3-piperidinopropoxy)quinazolin-4-yl]piperazine-1-carboxamide;NCGC00241097-07;NSC-726292;Tandutinib [USAN:INN];BDBM13535;HMS3244A21;Tandutinib(MLN518);BCPP000051;D06005;MLS006010972;NCGC00241097-03;CHEMBL124660;4-[7-(3-Piperidin-1-yl-propoxy)-quinazolin-4-yl]-piperazine-1-carboxylic acid (4-isopropoxy-phenyl)-amide;FT-0653217;SCHEMBL927974;387867-13-2;SW218125-2;NSC-800942;A824282;MLN518, Tandutinib;SB19380;ES-0051;s1043;NCGC00241097-02;CS-0128;AKOS015902621;4-[6-methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-yl]-N-[4-(1-methylethoxy)phenyl]piperazine-1-carboxamide;4-{6-methoxy-7-[3-(piperidin-1-yl)propoxy]quinazolin-4-yl}-N-[4-(propan-2-yloxy)phenyl]piperazine-1-carboxamide;Tandutinib pound MLN518, CT53518 pound(c);Kinome_3320;4-[6-methoxy-7-[3-(1-piperidinyl)propoxy]-4-quinazolinyl]-N-(4-propan-2-yloxyphenyl)-1-piperazinecarboxamide;Q-201778;NSC760841;CCG-213017;4-(6-Methoxy-7-(3-(piperidin-1-yl)propoxy)quinazolin-4-yl)-N-(4-(1-methylethoxy)phenyl)piperazine-1-carboxamide;CAS-387867-13-2;MFCD09954147;tandutinibum;BRD-K89162000-001-01-5;AB015... |
| CAS号: | 387867-13-2 |
| 分子式: | C31H42N6O4 |
| 分子量: | 562.70 |
| 密度: | |
| 熔点: | |
| 沸点: | |
| 闪点: | |
| 水溶性: | |
| 蒸气压: |
坦度替尼
英文名:
Tandutinib (MLN518)
别名:4-[6-甲氧基-7-(3-哌啶-1-基丙氧基)喹唑啉-4-基]-N-(4-异丙基氧苯基)哌嗪-1-甲酰胺;坦度替尼(标准品);坦度替尼;Tandutinib(MLN518) 抑制剂;坦度替尼Tandutinib;坦度替尼(对照品)
商品编号:R028636-500mg
规格:500mg
纯度:98%
CAS号: 387867-13-2
分子式:C31H42N6O4
分子量:562.70
| 价格 |
¥ 2172.00
(请 登录 会员查看折扣价)
|
| 货期 | 5~7个工作日 |
数量
搜索质检报告(COA)
搜索MSDS
相关产品


















